Abstract

Several clinical trials showed inconsistent results of the effect of isolating all versus arrhythmogenic pulmonary veins (PVs) on long-term control of atrial fibrillation (AF). We hypothesized that isolation of arrhythmogenic veins had a comparable success rate to the empiric isolation of all PVs. PUBMED, EMBASE, and the Cochrane Library were searched for randomized controlled trials and nonrandomized, observational studies. The efficacy and adverse events of isolating all versus arrhythmogenic PVs were presented as risk ratio (RR) with 95 % confidence intervals (CIs), and weighted mean differences and 95 % CIs were calculated to compare the procedure time and fluoroscopic time between the isolation all PVs and arrhythmogenic PVs. Six trials with 658 patients were included in the analysis. Isolation of arrhythmogenic PVs was as efficacious as empiric isolation of all PVs in achieving long-term AF control (RR, 0.96; 95 % CI, 0.87-1.05; p = 0.36). Isolation of arrhythmogenic PVs group had shorter procedure time, fluoroscopic time and fewer adverse events than the isolation of all PVs group. The present analysis suggests that isolation of arrhythmogenic veins had a comparable long-term success rate, shorter procedure time, fluoroscopic time, and fewer adverse events than the empiric isolation of all PVs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.